Adalimumab 80 mg/.8mL
adalimumab-adaz · INJECTION, SOLUTION · Sandoz Inc
1 Recall on RecordCurrently in Shortage
Plain English
Adalimumab is a injection, solution containing adalimumab-adaz at 80 mg/.8mL, taken subcutaneous. Manufactured by Sandoz Inc.
Key Facts
- Brand Name
- Adalimumab
- Generic Name
- adalimumab-adaz
- NDC Code (Product)
61314-325- Manufacturer
- Sandoz Inc
- Strength
- 80 mg/.8mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761071
- Drug Class
- Tumor Necrosis Factor Blocker [EPC]
- Marketing Start
- 01/06/2025
Recall History
1 Recall on Record
Class II10/10/2025
Samsung Bioepis Co., Ltd.
Lack of Assurance of Sterility.
OngoingVoluntary: Firm initiated
Frequently Asked Questions
What is Adalimumab used for?
Adalimumab contains adalimumab-adaz. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Adalimumab a controlled substance?
Adalimumab is not classified as a controlled substance by the DEA.
What is the generic name for Adalimumab?
The generic name for Adalimumab is adalimumab-adaz. There are 10 other brand versions of adalimumab-adaz.
What is the NDC code for Adalimumab 80 mg/.8mL?
The NDC (National Drug Code) for Adalimumab 80 mg/.8mL is 61314-325, listed by Sandoz Inc.